HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population.

AbstractBACKGROUND AND PURPOSE:
Elevated high-density lipoprotein cholesterol (HDL-C) levels have displayed protection against cardiovascular disease. However, the association between specific lipoprotein classes and first ischemic stroke (IS) has not been well defined, particularly in higher-risk hypertensive populations. Our study evaluated the associations of HDL-C with first IS in a Chinese hypertensive population.
METHODS:
The study population was obtained from a community-based cohort study of hypertension in Lianyungang and Rongcheng, China. A nested case-control design was used that included 2463 identified first IS cases and 2463 controls matched by age ± 1 year, sex, and region.
RESULTS:
After adjusting for potential confounders, HDL-C was inversely associated with first IS (adjusted odds ratio [aOR]: 0.91; 95% confidence interval [CI]: 0.85-0.98). HDL-C levels of at least 65.4 mg/dL displayed a significant protective effect for first IS (aOR: 0.82; 95% CI: 0.69-0.98). Conversely, adverse effects of first IS were observed for low-density lipoprotein cholesterol (LDL-C) levels ≥138.1 mg/dL (aOR: 1.20; 95% CI: 1.02-1.42) and triglyceride (TG) levels ≥140.8 mg/dL (aOR: 1.27; 95% CI: 1.09-1.49). The risk associations of LDL-C and TG with first IS were attenuated in the presence of high HDL-C (≥53.0 mg/dL); an increased risk of first IS was only found in the presence of low HDL-C (<53.0 mg/dL) when LDL-C (aOR: 1.66; 95% CI: 1.19-2.31) and TG (aOR: 1.47; 95% CI: 1.17-1.84) were combined with HDL-C for analysis.
CONCLUSION:
In this community-based Chinese hypertensive population, higher HDL-C was a significant protective factor of first IS. These data add to the evidence describing the relationship between lipids and IS and suggest that HDL-C maybe is a marker of IS risk in Chinses hypertensive population.
AuthorsYue Zhang, Jingyi Li, Chengzhang Liu, Hongxiang Yu, Chen Chen, Chonglei Bi, Chongqian Fang, Hai Ma, Aimin Li, Qing Dong, Lishun Liu, Binyan Wang, Xiao Huang, Xiaoshu Cheng, Pierre Zalloua, Xiping Xu, Yong Huo, Gang Li
JournalClinical interventions in aging (Clin Interv Aging) Vol. 16 Pg. 801-810 ( 2021) ISSN: 1178-1998 [Electronic] New Zealand
PMID34017170 (Publication Type: Journal Article)
Copyright© 2021 Zhang et al.
Chemical References
  • Biomarkers
  • Cholesterol, HDL
  • Lipids
Topics
  • Aged
  • Biomarkers
  • Case-Control Studies
  • China (epidemiology)
  • Cholesterol, HDL (blood)
  • Female
  • Humans
  • Hypertension (epidemiology, physiopathology)
  • Ischemic Stroke (epidemiology, physiopathology)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Odds Ratio
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: